Vantage logo

Covid-19 research efforts slow

A few developers are still finding reasons to research novel pandemic treatments, though much of the ongoing work is focused on proven approaches.

Vantage logo

EQRX aims for biopharma Spac record

Spac redemptions are a growing concern, but the $1.8bn EQRX deal looks primed to succeed. Proving the business model will be the hard part.